id | C00001015 |
---|---|
Name | Amentoflavone |
CAS RN | 1617-53-4 |
Standard InChI | InChI=1S/C30H18O10/c31-15-4-1-13(2-5-15)24-12-23(38)29-21(36)10-20(35)27(30(29)40-24)17-7-14(3-6-18(17)33)25-11-22(37)28-19(34)8-16(32)9-26(28)39-25/h1-12,31-36H |
Standard InChI (Main Layer) | InChI=1S/C30H18O10/c31-15-4-1-13(2-5-15)24-12-23(38)29-21(36)10-20(35)27(30(29)40-24)17-7-14(3-6-18(17)33)25-11-22(37)28-19(34)8-16(32)9-26(28)39-25/h1-12,31-36H |
Phytochemical cluster | No. 18 |
---|---|
KCF-S cluster | No. 34 |
By standard InChI | CHEMBL63354 |
---|---|
By standard InChI Main Layer | CHEMBL63354 |
By LinkDB | C10018 |
---|
By CAS RN | C011164 |
---|
class name | count |
---|---|
Spermatophyta | 23 |
rosids | 11 |
Euphyllophyta | 2 |
Embryophyta | 2 |
asterids | 1 |
family name | count |
---|---|
Cupressaceae | 10 |
Araucariaceae | 3 |
Podocarpaceae | 3 |
Taxaceae | 3 |
Cycadaceae | 2 |
Selaginellaceae | 2 |
Zamiaceae | 2 |
Calophyllaceae | 2 |
Anacardiaceae | 1 |
Salicaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | CHEMBL63354 |
CHEMBL1614529
(1)
|
0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL63354 |
CHEMBL1794585
(1)
|
0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL63354 |
CHEMBL1614554
(1)
|
3 / 1 |
O15496 | Group 10 secretory phospholipase A2 | Enzyme | CHEMBL63354 |
CHEMBL922765
(1)
|
0 / 0 |
P49763 | Placenta growth factor | Unclassified protein | CHEMBL63354 |
CHEMBL2339396
(1)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL63354 |
CHEMBL926465
(1)
CHEMBL926470
(1)
|
0 / 0 |
P14555 | Phospholipase A2, membrane associated | Enzyme | CHEMBL63354 |
CHEMBL866283
(1)
|
0 / 0 |
P43235 | Cathepsin K | C1A | CHEMBL63354 |
CHEMBL913665
(1)
|
1 / 2 |
P47712 | Cytosolic phospholipase A2 | Enzyme | CHEMBL63354 |
CHEMBL922766
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL63354 |
CHEMBL1614458
(1)
|
0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | CHEMBL63354 |
CHEMBL1794495
(1)
|
2 / 2 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL63354 |
CHEMBL1794486
(1)
|
0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL63354 |
CHEMBL1794584
(1)
|
2 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL63354 |
CHEMBL679083
(1)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL63354 |
CHEMBL926464
(1)
CHEMBL926467
(1)
CHEMBL926472 (1) CHEMBL1120978 (1) |
0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL63354 |
CHEMBL2114788
(1)
|
0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL63354 |
CHEMBL2114810
(1)
|
7 / 3 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL63354 |
CHEMBL1794569
(1)
|
1 / 1 |
P15692 | Vascular endothelial growth factor A | Secreted protein | CHEMBL63354 |
CHEMBL2339393
(1)
|
1 / 2 |
P56817 | Beta-secretase 1 | A1A | CHEMBL63354 |
CHEMBL1211753
(1)
|
0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | CHEMBL63354 |
CHEMBL945961
(1)
|
1 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL63354 |
CHEMBL1614038
(1)
|
2 / 2 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL63354 |
CHEMBL617859
(1)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL63354 |
CHEMBL926466
(1)
CHEMBL926471
(1)
|
0 / 0 |
P19174 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Enzyme | CHEMBL63354 |
CHEMBL974195
(1)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL63354 |
CHEMBL1794483
(1)
|
0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL63354 |
CHEMBL1737991
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL63354 |
CHEMBL1614250
(1)
CHEMBL1614421
(1)
CHEMBL1614502 (1) |
4 / 3 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL63354 |
CHEMBL1794536
(1)
|
0 / 0 |
P55072 | Transitional endoplasmic reticulum ATPase | Unclassified protein | CHEMBL63354 |
CHEMBL1614506
(1)
CHEMBL1614140
(1)
|
2 / 1 |
O00255 | Menin | Unclassified protein | CHEMBL63354 |
CHEMBL1614257
(1)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL63354 |
CHEMBL1614257
(1)
|
1 / 3 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
CHEMBL678813 (1) CHEMBL678814 (1) |
1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
CHEMBL678813 (1) CHEMBL678814 (1) |
0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
CHEMBL678813 (1) CHEMBL678814 (1) |
4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | CHEMBL63354 |
CHEMBL650540
(1)
CHEMBL685374
(1)
|
1 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | CHEMBL63354 |
CHEMBL2114738
(1)
|
0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | CHEMBL63354 |
CHEMBL2114796
(1)
|
2 / 1 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C011164 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | amentoflavone results in decreased activity of CYP1B1 protein |
decreases activity
|
protein |
16271822
|
C011164 | 1638 |
DCT
TRP-2 TYRP2 |
dopachrome tautomerase (EC:5.3.3.12) | amentoflavone analog results in decreased expression of DCT mRNA |
decreases expression
|
mRNA |
17473463
|
C011164 | 1638 |
DCT
TRP-2 TYRP2 |
dopachrome tautomerase (EC:5.3.3.12) | amentoflavone analog results in decreased expression of DCT protein |
decreases expression
|
protein |
17473463
|
C011164 | 4843 |
NOS2
HEP-NOS INOS NOS NOS2A |
nitric oxide synthase 2, inducible (EC:1.14.13.39) | amentoflavone results in decreased expression of NOS2 protein |
decreases expression
|
protein |
12144868
|
C011164 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | amentoflavone results in decreased expression of PTGS2 mRNA |
decreases expression
|
mRNA |
12144868
|
C011164 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | amentoflavone results in decreased expression of PTGS2 protein |
decreases expression
|
protein |
12144868
|
C011164 | 5743 |
PTGS2
COX-2 COX2 GRIPGHS PGG/HS PGHS-2 PHS-2 hCox-2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) | [amentoflavone results in decreased expression of PTGS2 protein] which results in decreased chemical synthesis of Dinoprostone |
decreases chemical synthesis
/ decreases expression |
protein |
12144868
|
C011164 | 7299 |
TYR
ATN CMM8 OCA1 OCA1A OCAIA SHEP3 |
tyrosinase (EC:1.14.18.1) | amentoflavone analog results in decreased activity of TYR protein |
decreases activity
|
protein |
17473463
|
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#103780 | Alcohol dependence |
P47869
|
#613954 | Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia; als14 |
P55072
|
#114500 | Colorectal cancer; crc |
P84022
Q14191 |
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P18507
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#167320 | Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 1; ibmpfd1 |
P55072
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#603933 | Microvascular complications of diabetes, susceptibility to, 1; mvcd1 |
P15692
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#265800 | Pycnodysostosis |
P43235
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277700 | Werner syndrome; wrn |
Q14191
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H00025 | Penile cancer |
P08253
(related)
|
H00028 | Choriocarcinoma |
P08253
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
P55072 (related) |
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00018 | Gastric cancer |
P15692
(related)
|
H00021 | Renal cell carcinoma |
P15692
(marker)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00273 | Pycnodysostosis |
P43235
(related)
|
H00425 | Lysosomal cysteine protease deficiencies |
P43235
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00296 | Defects in RecQ helicases |
Q14191
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|